Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
10/2009
10/14/2009EP1856082B1 Glucopyranosyl-substituted ((hetero)arylethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009CN101558058A Modulators of CB1 receptors
10/14/2009CN101558040A Dihydropyridine derivatives useful as protein kinase inhibitors
10/14/2009CN100548992C Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
10/14/2009CN100548978C Pyrrolidinium derivatives as antagonists of M3 muscarinic receptors
10/14/2009CN100548299C Excitatory amino acid receptor antagonists
10/13/2009US7601850 less hypercalcemic than 1a,25 dihydroxy vitamin D3; bone disorders, psoriasis
10/13/2009US7601849 Phenyl-tetracyanobutadienyl thiophene-stilbene-based NLO chromophore; films; heat resistance
10/13/2009US7601752 Pyrrolidine derivatives
10/13/2009US7601738 Excitatory amino acid receptor antagonists
10/13/2009US7601729 Matrix metalloproteinase inhibitors
10/13/2009US7601503 sequence-selective nucleic acid detection; polythiophenes containing pendant quaternary ammonium groups that are thermostable and autoclavable; use in DNA or RNA electrochemical or optical detection, or purification; diagnosis of infections or disease
10/13/2009CA2386974C Benzodiazepine derivatives for use in acute or chronic neurological disorders
10/13/2009CA2368274C C10 ester substituted taxanes as antitumor agents
10/13/2009CA2341678C Potassium channel inhibitors and method
10/08/2009WO2009123948A2 Compounds and compositions as itpkb inhibitors
10/08/2009WO2009123194A1 Heterocyclic compound
10/08/2009WO2009123154A1 Ultraviolet absorbing material
10/08/2009WO2009123153A1 Polymer material containing ultraviolet absorbent
10/08/2009WO2009123142A1 Ultraviolet absorbent compositions
10/08/2009WO2009123141A1 Ultraviolet absorbent compositions
10/08/2009WO2009122968A1 Resin molded product and polymer film
10/08/2009WO2009122180A1 Pyrimidine derivatives capable of inhibiting one or more kinases
10/08/2009WO2009121910A1 Indene derivatives as estrogen receptor ligands
10/08/2009WO2009121872A2 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
10/08/2009WO2008112022A8 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
10/08/2009US20090253918 Novel intermediate for glyt1 inhibitor
10/08/2009US20090253908 Novel m3 muscarinic acetylchoine receptor antagonists
10/08/2009US20090253906 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
10/08/2009US20090253767 Aminoindazolylurea derivatives
10/08/2009US20090253751 Hydrazide compound and thrombopoietin receptor activator
10/08/2009US20090253711 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
10/08/2009US20090253694 Fused hetrocyclic compounds
10/08/2009US20090253684 Leukotriene b4 inhibitors
10/08/2009US20090253656 Bcrp/abcg2 inhibitor
10/08/2009US20090253655 Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
10/08/2009DE102009016750A1 Farbstoffverbindung Dye compound
10/08/2009CA2720490A1 Compounds and compositions as itpkb inhibitors
10/08/2009CA2720004A1 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
10/07/2009EP2106398A2 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase (scd)
10/07/2009EP1309566B1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
10/07/2009EP1308441B1 2-aminopyridine compounds and use thereof as drugs
10/07/2009EP0861247B1 Novel imidazole n-benzyldioxol derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists
10/07/2009CN101553468A Organic compounds
10/07/2009CN101550104A Benzene-naphthalene diimide derivative, preparation method and its application
10/06/2009US7598394 Made by reacting a cyano compound with a silylalkylisocyanide compound; silylimidazole ;
10/06/2009US7598384 Specific binding is extremely high; low toxicity; high degree of activity; 2-(5-m-Tolyl-thiazol-2-yl )-7,8-dihydro-6H-quinolin-5-one, acute and/or chronic neurological disorders
10/06/2009US7598378 Reacting 4-(4-nitrophenyl)-3-morpholinone with hydrogen in the presence of a hydrogenation catalyst, characterized in that reaction is effected in an aliphatic alcohol; precursor in synthesis of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
10/06/2009US7598288 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
10/06/2009US7598268 Vascular endothelial growth factor; tyrosine kinase inhibitor;angiogenesis inhibitor; anticarcinogenic agents
10/06/2009US7598260 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
10/06/2009US7598251 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents
10/06/2009US7598250 for treating neurodegenerative disease such as Alzheimer's disease
10/06/2009CA2402431C 1,2,3,4-tetrahydroisoquinoline derivatives
10/01/2009WO2009121033A2 Substituted nitrogen heterocycles and synthesis and uses thereof
10/01/2009WO2009119167A1 Aniline derivative having anti-rna viral activity
10/01/2009WO2009119088A1 Heterocyclic compound
10/01/2009WO2009118765A2 Novel monoamine re-uptake inhibitor
10/01/2009WO2009118254A1 Aminopiperidinyl derivatives and uses thereof
10/01/2009WO2009095399A3 Pyrazine derivatives and their use as protein kinase inhbitors
10/01/2009US20090247766 Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof
10/01/2009US20090247746 Fused heterocyclic compound
10/01/2009US20090247745 adenosine A3 receptor antagonists; improved bioavailability; treatment of diseases such as asthma, COPD and ARDS, glaucoma, tumor, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases; e.g. 4-Methoxy-N-[6-(morpholin-4-yl)-4-benzylamino-3-cyanoquinolin-2-yl]-benzamide
10/01/2009US20090247596 Thiophenecarboxamide derivatives as ep4 receptor ligands
10/01/2009US20090247554 Kinase inhibitors
10/01/2009US20090247526 Glucokinase activators
10/01/2009US20090247513 Benzothiophene compounds having antiinfective activity
10/01/2009US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders
10/01/2009US20090247474 3-Aminopyrrolidine Derivatives As Modulators Of Chemokine Receptors
10/01/2009US20090246819 Assay Methods Using Chemiluminescent Detection of Peroxidase
10/01/2009US20090242837 Charge transport compositions and electronic devices made with such compositions
10/01/2009CA2718727A1 Heterocyclic compound
10/01/2009CA2712468A1 Aminopiperidinyl derivatives and uses thereof
09/2009
09/30/2009EP2105442A1 Method for producing c-glycoside derivative and synthetic intermediate thereof
09/30/2009EP2105441A1 Alanyl aminopeptidase and dipeptidylpeptidase IV dual inhibitors for the treatment of immunological, inflammatory, neuronal and other illnesses
09/30/2009EP2105436A1 Lactam-containing compounds and derivatives thereof as factor XA inhibitors
09/30/2009EP2104670A2 Novel triazinedione derivatives as gaba-b receptor modulators
09/30/2009EP2104669A2 Inhibitors of akt activity
09/30/2009EP1711181B1 Quinoline derivatives and use thereof as mycobacterial inhibitors
09/30/2009EP1581523B1 Pyrazole-derivatives as factor xa inhibitors
09/30/2009EP1435944B1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
09/29/2009US7595343 Inhibitors of histone deacetylase
09/29/2009US7595339 Such as N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; Cannabinoid-1 (CB1) receptor; dietetics
09/29/2009US7595336 Isatine derivatives with neurotrophic activity
09/29/2009US7595330 Such as 5-{6-[(Methylsulfonyl)methyl]-1H-benzimidazol-1-yl}-3-({(1R)-1-[2-(trifluoromethyl)phenyl]-ethyl}oxy)-2-thiophenecarboxamide; for conditions associated with polo-like kinases
09/29/2009US7595321 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(2-cyanoethyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example
09/29/2009US7595320 Hydrazinocarbonyl-thieno[2,3-C]pyrazoles, process for preparing them, compositions containing them and use thereof
09/29/2009US7595319 Compounds having selective inhibiting effect at GSK3
09/29/2009CA2379026C Substituted thiene-3-yl-sulphonylamino(thio)carbonyl-triazolin(thi)ones
09/24/2009WO2009117109A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
09/24/2009WO2009116883A2 Catalytic asymetric hydrogenation
09/24/2009WO2009116290A1 4-halogenobenzoyl derivatives having sulfoxyimino group and herbicides
09/24/2009WO2009116075A2 Process for preparation of tazarotene
09/24/2009WO2009115427A1 Pyrrolidinyl derivatives and uses thereof
09/24/2009WO2009087212A3 Pyridine derivatives
09/24/2009WO2009032668A3 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors
09/24/2009US20090240062 Compound derived from cyclopentadienone, preparation method thereof and el element using the same
09/24/2009US20090239867 1-(2,4-Dimethoxybenzyl)-5-oxo-pyrrolidine-3-carboxylic Acid Methyl Ester; for treating inflammatory bowel disease, glaucoma or ocular hypertension, asthma or baldness; prostaglandin EP2 agonists
09/24/2009US20090239866 Peptide deformylase inhibitors
1 ... 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 ... 523